相关实验视频
Updated: Jul 17, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
758
由于阿尔茨海默病的认知刺激,改善了连接和认知能力
Qumars Behfar1,2, Nils Richter1,2, Merve Kural2
1Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Juelich Research Centre, Jülich, Germany.
Frontiers in aging neuroscience
|September 4, 2023
概括
认知刺激疗法 (CST) 改善了阿尔茨海默病 (AD) 患者的认知和行为. 这种非药物方法增强了大脑的连接,为管理AD痴呆症提供了一个有希望的途径.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 心理学 心理学 心理学
背景情况:
- 阿尔茨海默病 (AD) 越来越普遍,药物治疗选择有限.
- 像认知刺激疗法 (CST) 这样的非药物干预在AD管理方面越来越感兴趣.
- CST旨在改善阿兹海默症患者的认知功能和生活质量.
研究的目的:
- 为了评估一个CST程序对AD痴呆症患者的疗效.
- 为了研究CST的认知和行为效益背后的神经机制.
- 评估CST后神经心理状态和大脑连接性的变化.
主要方法:
- 一个随机对照试验,比较CST干预与无干预对照组.
- 神经心理测试包括MMSE,ADAS-cog和BPSD评估.
- 基于MRI的静止状态功能连接的测量.
主要成果:
- 在CST.之后,在MMSE,ADAS-cog和BPSD得分上观察到显著的改善.
- 认知收益与海马体和后中心环之间功能连接的增加相关.
- 在学习和记忆区域中,CST增强了静止状态的功能连接.
结论:
- 在轻度至中度的AD痴呆症中,CST在改善全球认知和行为方面表现出短期的有效性.
- CST对学习和记忆至关重要的大脑区域的功能连接有积极的影响.
- 神经可塑性可以通过CST来利用,以缓解AD的认知障碍.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Cognitive Development During Adulthood
155
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Role of Neurotransmitters in Memory
623
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
623
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139

